| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |